Maternity Deserts, AI Bias, and the Future of Women's Health Tech with Anoushka Gungadin in Building HeraMed

What if the data collected during your pregnancy could predict and even prevent - a heart attack, a stroke, or dementia decades later? That's not a distant vision. That's exactly what HeraMed is building right now.

Anoushka Gungadin's path to CEO of HeraMed is anything but straight from growing up in Mauritius, to a decade in China, to building a leadership practice in Australia. And it's that exact breadth of experience that shapes the way she thinks about women's health. Because in her world, one size has never, and should never, fit all.

This is a conversation about technology, equity, and what it truly looks like to build healthcare that's designed around the woman not the other way around.

Key Takeaways:

• Find out how a girl from Mauritius who detoured through China and corporate boardrooms ended up leading one of the most exciting companies in women's health
• Discover how HeraMed quietly grew from a single device into a full women's health platform and what that journey reveals about where personalized care is actually headed
• Learn the link your doctor probably never mentioned, what happens in your pregnancy and what it could mean for your heart, your brain, and your body decades down the line
• Find out why AI is failing women 60% of the time right now and how HeraMed is tackling a bias that most of the health tech world isn't even willing to admit exists
• Discover what a "maternity desert" really means and why the scale of the problem in the US is what brought an Australian company all the way across the Pacific
• Learn the one thing that makes or breaks clinician buy-in for health tech innovation and why it has nothing to do with how impressive your technology is
• Find out what Anoushka thinks is quietly getting in the way of real progress in Australia's femtech space and why she believes the industry's biggest unlock isn't funding, it's each other
• Discover why being the only ASX-listed femtech company is not the win it sounds like and what it actually tells us about how far women's health investment still has to go

Resources:

Anoushka Gungadin: LinkedIn

HeraMed: LinkedIn

HeraMed: hera-med.com

Maaike Steinebach: LinkedIn

Website Femtech Future: https://www.femtechfuture.com

Instagram Femtech Future: @femtech_future

Anoushka isn't just building a platform, she's building a future where a woman's health data actually follows her, protects her, and works for her at every stage of life. That vision is rare. And it deserves to be heard.

If this episode resonated with you, share it with a woman in your life who deserves better from her healthcare. Like it, leave a review, and help us keep putting these conversations in front of the people who need them most. Thank you, and see you next week for another episode of Femtech At Work.